Integrating Behavioral Health and Primary Care (IBH-PC) to improve patient-centered outcomes in adults with multiple chronic medical and behavioral health conditions: study protocol for a pragmatic cluster-randomized control trial
Abstract Background Chronic diseases that drive morbidity, mortality, and health care costs are largely influenced by human behavior. Behavioral health conditions such as anxiety, depression, and substance use disorders can often be effectively managed. The majority of patients in need of behavioral...
Main Authors: | Abigail M. Crocker, Rodger Kessler, Constance van Eeghen, Levi N. Bonnell, Ryan E. Breshears, Peter Callas, Jessica Clifton, William Elder, Chet Fox, Sylvie Frisbie, Juvena Hitt, Jennifer Jewiss, Roger Kathol, Kelly Clark/Keefe, Jennifer O’Rourke-Lavoie, George S. Leibowitz, C. R. Macchi, Mark McGovern, Brenda Mollis, Daniel J. Mullin, Zsolt Nagykaldi, Lisa Watts Natkin, Wilson Pace, Richard G. Pinckney, Douglas Pomeroy, Alexander Pond, Rachel Postupack, Paula Reynolds, Gail L. Rose, Sarah Hudson Scholle, William J. Sieber, Terry Stancin, Kurt C. Stange, Kari A. Stephens, Kathryn Teng, Elizabeth Needham Waddell, Benjamin Littenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05133-8 |
Similar Items
-
Glaucoma clinical trial design: A review of the literature
by: William C. Stewart, et al.
Published: (2014-01-01) -
Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the “ideal” patient
by: Jennifer A. H. Bell, et al.
Published: (2020-06-01) -
The Potential of Trial-by-Trial Variabilities of Ongoing-EEG, Evoked Potentials, Event Related Potentials and fMRI as Diagnostic Markers for Neuropsychiatric Disorders
by: Carlos Trenado, et al.
Published: (2019-07-01) -
The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
by: Jack Cotter, et al.
Published: (2019-09-01) -
Registration of phase 3 crossover trials on ClinicalTrials.gov
by: Lijuan Zeng, et al.
Published: (2020-07-01)